ONCOLOGY Nurse Edition Vol 24 No 10

Oncology nurses must play an integral role in improving the treatment of breakthrough pain-one patient, one in-service for colleagues, and one clinical research study at a time.

Franklin, Delengowski, and Yeo have made a strong case for the importance of cancer rehabilitation.

The assessment and management of breakthrough pain in patients with cancer is pivotal to comprehensive pain and symptom management, and good cancer care.

The 5-year survival rate of cancer patients in the United States is about 66%, and today there are approximately 12 million cancer survivors in the US.

Mindfulness meditation and other mindfulness-based practices are gaining popularity due to a burgeoning evidence base supporting its benefits for a broad range of conditions and populations, including cancer patients[1] and healthcare professionals.

Current advances in the field of medicine have aided in the early detection and treatment of cancer, leading to an increased rate of survivorship among cancer patients after an initial diagnosis.

Cabazitaxel is a microtubule inhibitor in the taxane class. It is made from a yew needle precursor using a semisynthetic process. It binds to free tubulin, which is used during mitosis to form two daughter cells.

The increasing national and international attention to October as Breast Cancer Awareness Month brings to mind the tremendous progress made by the women’s rights movement over the last few decades.

ONCOLOGY Nurse Edition Continuing Medical Education October 2010